Nibec KRX:138610KOSDAQ

나이벡 · Korean news coverage and regulatory filings, organized.

Articles, 24h1
Articles, 7 days3
DART filings, 7 days1
Articles tracked27since Sep 11

In Q3 2026, Nibec reported revenue of ₩4.5bn, down 13.0% year on year, and an operating loss of ₩783m. Nibec (나이벡) appeared in 3 Korean news articles and 1 DART filing over the past seven days. Coverage peaked on Nov 9 with 4 articles. The most common catalyst was contracts & orders (2). It was most often mentioned alongside 글로벌테크놀로지, Jeil Pharmaceutical and LigaChem Biosciences.

Nibec today: up or down?

No sign-up, one tap a day. These numbers show what visitors think and are not investment advice.

Upcoming dates as filed

  • Mar 31 Annual report filing deadlinein 135 days · period ending Dec 2026

Dates Nibec stated in its DART filings. A conversion period opening does not mean new shares appear that day; bondholders must request conversion.

Nibec quarterly results separate, KRW

QuarterRevenueYoYOperating profitNet income
Q3 2026₩4.5bn-13.0%−₩783m
margin −17.4%
−₩3.2bn
Q2 2026₩6.1bn-61.6%₩103m
margin 1.7%
₩381m
Q1 2026₩5.2bn-6.7%₩137m
margin 2.6%
₩1.1bn
Q4 2025 derived₩6.1bn-3.8%−₩1.2bn
margin −18.8%
−₩1.1bn
Q3 2025₩5.2bn-10.7%−₩993m
margin −19.2%
−₩454m
Q2 2025₩15.8bn+165.0%₩8.4bn
margin 53.1%
₩7.7bn
Q1 2025₩5.6bn-12.6%−₩1.2bn
margin −21.8%
−₩1.5bn
Q4 2024 derived₩6.4bn+37.4%−₩5.8bn
margin −90.8%
−₩2.6bn

Nibec ranks #1708 of 2,345 Korean listed companies by Q3 2026 operating profit. Q3 2026 Korean earnings rankings →

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

Nibec top stories 2 weeks, by number of outlets

  1. 1
    NaiVec pursues new drug commercialization for obesity and cardiometabolic disease at BioEurope
    2 outlets · 2 articlesFirst report Nov 9 09:38 바이오타임즈
  2. 2
  3. 3
    Naiveck showcases bone graft and collagen materials at American Academy of Periodontology
    1 outlets · 1 articlesFirst report Nov 3 06:19 메디포뉴스
  4. 4
  5. 5
    Naivec pursues peptide new drug and delivery platform collaboration at BioEurope
    1 outlets · 1 articlesFirst report Nov 10 09:14 메디포뉴스
  6. 6
    Naevik regenotide shows weight and liver fat reduction in obese mice at ObesityWeek 2026
    1 outlets · 1 articlesFirst report Nov 15 08:25 메디코파마

Latest Nibec news Korean headlines